Therefore, we took a systematic approach whereby we performed mRNA profiling on tumor endothelial cells obtained from mouse models with adaptive resistance to AVA and identified CD5L as the most highly upregulated mRNA in treatment-resistant endothelial cells. This evidence concerns the gene CD5L and neoplasm.